Research on continuous or intermittent administration of recombinant human endostatin by intraperitoneal injection in mice H22 ascite tumor model

ZHENG Yan-hua; WANG Lin; JIANG Zi-yu; QIN Shu-kui

doi:10.3969/j.issn.1009-0460.2012.03.003

Home>Articles>Research on continuous or intermittent administration of recombinant human endostatin by intraperitoneal injection in mice H22 ascite tumor model

DOI: 10.3969/j.issn.1009-0460.2012.03.003

Research on continuous or intermittent administration of recombinant human endostatin by intraperitoneal injection in mice H22 ascite tumor model

ZHENG Yan-hua

WANG Lin

JIANG Zi-yu

QIN Shu-kui

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 202-206 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2012,17(3)